ArticleWorld journal of urology2026
Global, regional, and national burden of urolithiasis among children and adolescents, 1990-2021, with forecasts to 2050: a systematic analysis of the Global Burden of Disease Study 2021.
Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeUrolithiasis exhibits a high recurrence rate and aggressive disease progression in youths. Current study aims to analyze the global, regional, and national burdens and trends of urolithiasis among children and adolescents based on the Global Burden of Disease (GBD) 2021 database.
methodsWe extracted four major indicators that related to urolithiasis among children and adolescents (aged 0-19 years) from GBD between 1990 and 2021, including incidence, prevalence, disability-adjusted life years (DALYs), and death. The changing trends in the burden of urolithiasis were assessed using the Estimated Annual Percentage Change (EAPC). Future changes in the disease burden through 2050 were forecasted.
resultsGlobal prevalence and incidence rates of urolithiasis among children and adolescents under 20 years had increased with EAPC of 0.06 (95% CI: 0.01 to 0.11) and 0.08 (95% CI: 0.03 to 0.12), while mortality and DALYs rates had decreased with EAPC of -2.75 (95% CI: -2.89 to -2.62) and - 1.66 (95% CI: -1.75 to -1.56). In 2021, the highest absolute cases of incidence, prevalence, and DALYs were observed in the low-middle socio-demographic index (SDI) regions. Additionally, the projections revealed an ongoing upward trajectory in the incidence and prevalence.
conclusionFrom 1990 to 2021, the global burden of urolithiasis among children and adolescents under 20 years had significantly increased, particularly in the low-middle SDI regions. This trend is projected to continue, further exacerbating the disease burden. These findings highlight the critical need for personalized interventions and lifestyle guidance on these patients.
Indexed as
Identifiers
42733045What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.